Jazz Pharms Drug Patent Portfolio
Jazz Pharms owns 2 orange book drugs protected by 44 US patents Given below is the list of Jazz Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10213400 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Sep, 2033 | Active |
| US10864181 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Sep, 2033 | Active |
| US11253494 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Sep, 2033 | Active |
| US8772306 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Sep, 2033 | Active |
| US9050302 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Sep, 2033 | Active |
| US9486426 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Sep, 2033 | Active |
| US10213400 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US10864181 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US11253494 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US11986446 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US8772306 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US9050302 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US9486426 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | 15 Mar, 2033 | Active |
| US7668730 | Sensitive drug distribution system and method | 16 Dec, 2024 | Active |
| US7765106 | Sensitive drug distribution system and method | 16 Dec, 2024 | Active |
| US7765107 | Sensitive drug distribution system and method | 16 Dec, 2024 | Active |
| US7668730 | Sensitive drug distribution system and method | 16 Jun, 2024 | Expired |
| US7765106 | Sensitive drug distribution system and method | 16 Jun, 2024 | Expired |
| US7765107 | Sensitive drug distribution system and method | 16 Jun, 2024 | Expired |
| US7895059 | Sensitive drug distribution system and method | 17 Jun, 2023 | Expired |
| US8457988 | Sensitive drug distribution system and method | 17 Jun, 2023 | Expired |
| US8589182 | Sensitive drug distribution system and method | 17 Jun, 2023 | Expired |
| US8731963 | Sensitive drug distribution system and method | 17 Jun, 2023 | Expired |
| US7895059 | Sensitive drug distribution system and method | 17 Dec, 2022 | Expired |
| US8457988 | Sensitive drug distribution system and method | 17 Dec, 2022 | Expired |
| US8589182 | Sensitive drug distribution system and method | 17 Dec, 2022 | Expired |
| US8731963 | Sensitive drug distribution system and method | 17 Dec, 2022 | Expired |
| US6780889 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 04 Jan, 2021 | Expired |
| US7262219 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 04 Jan, 2021 | Expired |
| US6780889 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 04 Jul, 2020 | Expired |
| US7262219 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 04 Jul, 2020 | Expired |
| US7851506 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Jun, 2020 | Expired |
| US8263650 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Jun, 2020 | Expired |
| US8324275 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Jun, 2020 | Expired |
| US8859619 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Jun, 2020 | Expired |
| US8952062 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Jun, 2020 | Expired |
| US9539330 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Jun, 2020 | Expired |
| US7465462 | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations | 10 May, 2020 | Expired |
| US7851506 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Dec, 2019 | Expired |
| US8263650 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Dec, 2019 | Expired |
| US8324275 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Dec, 2019 | Expired |
| US8859619 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Dec, 2019 | Expired |
| US8952062 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Dec, 2019 | Expired |
| US9539330 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | 22 Dec, 2019 | Expired |
Latest Legal Activities on Jazz Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Jazz Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 May, 2024 | US10864181 |
|
Maintenance Fee Reminder Mailed
Critical
| 29 Apr, 2024 | US8263650 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 Apr, 2024 | US9486426 |
|
Expire Patent
Critical
| 27 Mar, 2023 | US7895059 (Litigated) |
|
Expire Patent
Critical
| 20 Mar, 2023 | US8952062 (Litigated) |
|
Expire Patent
Critical
| 16 Jan, 2023 | US7851506 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Nov, 2022 | US9050302 (Litigated) |
|
Expire Patent
Critical
| 21 Nov, 2022 | US8859619 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 10 Oct, 2022 | US7895059 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Oct, 2022 | US8952062 (Litigated) |
|
Expire Patent
Critical
| 29 Aug, 2022 | US7765107 (Litigated) |
|
Expire Patent
Critical
| 29 Aug, 2022 | US7765106 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Aug, 2022 | US10213400 |
|
Maintenance Fee Reminder Mailed
Critical
| 01 Aug, 2022 | US7851506 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 06 Jun, 2022 | US8859619 (Litigated) |
Jazz Pharms's Drug Patent Litigations
Jazz Pharms's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 20, 2008, against patent number US7668730. The petitioner , challenged the validity of this patent, with Dayton T. Reardan et al as the respondent. Click below to track the latest information on how companies are challenging Jazz Pharms's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8731963 | September, 2015 |
Final Written Decision
(22 Mar, 2017)
| Jazz Pharmaceuticals, Inc. | Par Pharmaceutical, Inc. et al. |
| US7765106 | August, 2015 |
Final Written Decision
(03 Jan, 2017)
| Jazz Pharmaceuticals, Inc. | Wockhardt Bio AG et al. |
| US8772306 | February, 2016 |
Terminated-Denied
(28 Jul, 2016)
| Jazz Pharmaceutical, Inc. | Amneal Pharmaceuticals LLC |
| US7668730 | January, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | PAR PHARMACEUTICAL, INC. et al. |
| US7668730 | August, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Wockhardt Bio AG et al. |
| US7765106 | January, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals LLC et al. |
| US7765107 | January, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals LLC et al. |
| US7765107 | August, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Wockhardt Bio AG et al. |
| US7895059 | January, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | PAR PHARMACEUTICAL, INC. |
| US7895059 | August, 2015 |
FWD Entered
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals LLC |
| US7895059 | August, 2015 |
FWD Entered
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Wockhardt Bio AG |
| US8457988 | January, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | PAR PHARMACEUTICAL, INC. |
| US8457988 | August, 2015 |
FWD Entered
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals LLC |
| US8457988 | August, 2015 |
FWD Entered
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Wockhardt Bio AG |
| US8589182 | January, 2015 |
FWD Entered
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals LLC |
| US8589182 | August, 2015 |
Final Written Decision
(27 Jul, 2016)
| Jazz Pharmaceuticals, Inc. | Wockhardt Bio AG et al. |
| US8772306 | October, 2015 |
Terminated-Settled
(23 May, 2016)
| Jazz Pharmaceutical, Inc. | Ranbaxy, Inc. |
| US9050302 | March, 2016 |
Terminated-Denied
(23 May, 2016)
| Jazz Pharmaceuticals Ireland Limited | RANBAXY INC |
| US8772306 | October, 2015 |
Terminated-Denied
(12 Apr, 2016)
| Jazz Pharmaceutical, Inc. | Par Pharmaceutical, Inc. |
| US7895059 | April, 2015 |
Terminated-Denied
(15 Oct, 2015)
| Jazz Pharmaceuticals, Inc. | Coalition for Affordable Drugs III LLC |
| US7765106 | August, 2014 |
Terminated-Denied
(09 Feb, 2015)
| Jazz Pharmaceuticals, Inc. | Roxane Laboratories, Inc. |
| US7765107 | August, 2014 |
Terminated-Denied
(09 Feb, 2015)
| Jazz Pharmaceuticals Inc. | Roxane Laboratories, Inc. |
| US7668730 | July, 2014 |
Terminated-Denied
(13 Jan, 2015)
| Jazz Pharmaceuticals, Inc. | PAR PHARMACEUTICAL, INC. |
| US7895059 | June, 2014 |
Terminated-Denied
(13 Jan, 2015)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals, LLC |
| US8457988 | July, 2014 |
Terminated-Denied
(13 Jan, 2015)
| Jazz Pharmaceuticals, Inc. | Amneal Pharmaceuticals, LLC |
| US8589182 | July, 2014 |
Terminated-Denied
(13 Jan, 2015)
| Jazz Pharmaceuticals, Inc. | PAR PHARMACEUTICAL, INC. |
| US7668730 | May, 2008 |
Decision
(31 Aug, 2009)
| Dayton T. Reardan et al | |
Jazz Pharms Drug Patents' Oppositions Filed in EPO
Jazz Pharms drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jul 23, 2018, by Hoffmann Eitle. This opposition was filed on patent number EP14709858A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP17200764A | Sep, 2020 | Ter Meer Steinmeister & Partner Patentanwälte mbB | Granted and Under Opposition |
| EP17200764A | Sep, 2020 | Hexal AG | Granted and Under Opposition |
| EP17200764A | Sep, 2020 | Zentiva, k.s. | Granted and Under Opposition |
| EP17200764A | Mar, 2020 | Hoffman Eitle Patent- und Rechtsanwälte Partnerschaftsgesellschaft mbB | Granted and Under Opposition |
| EP14709858A | Aug, 2018 | Hexal AG | Revoked |
| EP14709858A | Aug, 2018 | Ter Meer Steinmeister & Partner Patentanwälte mbB | Revoked |
| EP14709858A | Jul, 2018 | Hoffmann Eitle | Revoked |
Jazz Pharms's Family Patents
Jazz Pharms drugs have patent protection in a total of 21 countries. It's US patent count contributes only to 50.0% of its total global patent coverage. Click
below to unlock the full patent family tree.
Jazz Pharms Drug List
Given below is the complete list of Jazz Pharms's drugs and the patents protecting them.
1. Luvox Cr
Luvox Cr is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7465462 | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
10 May, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luvox Cr's drug page
2. Xyrem
Xyrem is protected by 43 patents, out of which 27 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10213400
(Pediatric)
| Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Sep, 2033
(8 years from now)
| Active |
| US10864181
(Pediatric)
| Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Sep, 2033
(8 years from now)
| Active |
| US11253494
(Pediatric)
| Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Sep, 2033
(8 years from now)
| Active |
| US8772306
(Pediatric)
| Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Sep, 2033
(8 years from now)
| Active |
| US9050302
(Pediatric)
| Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Sep, 2033
(8 years from now)
| Active |
| US9486426
(Pediatric)
| Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Sep, 2033
(8 years from now)
| Active |
| US10213400 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US10864181 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US11253494 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US11986446 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US8772306 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US9050302 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US9486426 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
15 Mar, 2033
(8 years from now)
| Active |
| US7668730
(Pediatric)
| Sensitive drug distribution system and method |
16 Dec, 2024
(a month from now)
| Active |
| US7765106
(Pediatric)
| Sensitive drug distribution system and method |
16 Dec, 2024
(a month from now)
| Active |
| US7765107
(Pediatric)
| Sensitive drug distribution system and method |
16 Dec, 2024
(a month from now)
| Active |
| US7668730 | Sensitive drug distribution system and method |
16 Jun, 2024
(4 months ago)
| Expired |
| US7765106 | Sensitive drug distribution system and method |
16 Jun, 2024
(4 months ago)
| Expired |
| US7765107 | Sensitive drug distribution system and method |
16 Jun, 2024
(4 months ago)
| Expired |
| US7895059
(Pediatric)
| Sensitive drug distribution system and method |
17 Jun, 2023
(1 year, 4 months ago)
| Expired |
| US8457988
(Pediatric)
| Sensitive drug distribution system and method |
17 Jun, 2023
(1 year, 4 months ago)
| Expired |
| US8589182
(Pediatric)
| Sensitive drug distribution system and method |
17 Jun, 2023
(1 year, 4 months ago)
| Expired |
| US8731963
(Pediatric)
| Sensitive drug distribution system and method |
17 Jun, 2023
(1 year, 4 months ago)
| Expired |
| US7895059 | Sensitive drug distribution system and method |
17 Dec, 2022
(1 year, 10 months ago)
| Expired |
| US8457988 | Sensitive drug distribution system and method |
17 Dec, 2022
(1 year, 10 months ago)
| Expired |
| US8589182 | Sensitive drug distribution system and method |
17 Dec, 2022
(1 year, 10 months ago)
| Expired |
| US8731963 | Sensitive drug distribution system and method |
17 Dec, 2022
(1 year, 10 months ago)
| Expired |
| US6780889
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
04 Jan, 2021
(3 years ago)
| Expired |
| US7262219
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
04 Jan, 2021
(3 years ago)
| Expired |
| US6780889 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
04 Jul, 2020
(4 years ago)
| Expired |
| US7262219 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
04 Jul, 2020
(4 years ago)
| Expired |
| US7851506
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Jun, 2020
(4 years ago)
| Expired |
| US8263650
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Jun, 2020
(4 years ago)
| Expired |
| US8324275
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Jun, 2020
(4 years ago)
| Expired |
| US8859619
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Jun, 2020
(4 years ago)
| Expired |
| US8952062
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Jun, 2020
(4 years ago)
| Expired |
| US9539330
(Pediatric)
| Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Jun, 2020
(4 years ago)
| Expired |
| US7851506 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Dec, 2019
(4 years ago)
| Expired |
| US8263650 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Dec, 2019
(4 years ago)
| Expired |
| US8324275 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Dec, 2019
(4 years ago)
| Expired |
| US8859619 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Dec, 2019
(4 years ago)
| Expired |
| US8952062 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Dec, 2019
(4 years ago)
| Expired |
| US9539330 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
22 Dec, 2019
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyrem's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List